Connect with us

coronavirus

#CoronavirusGlobalResponse - Commission joins the #COVID-19 Vaccine Global Access Facility (COVAX)

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

presidency

"No country, no continent can defeat the coronavirus on its own.

"We have to join forces. That is what the two campaigns Coronavirus Global Response and Global Goal Unite are doing.

"We raised almost €16 billion so far. And we set up a global cooperation framework, the ACT-Accelerator, together with our international partners, in particular the World Health Organization.

"This ACT-Accelerator will enable us to develop and deploy vaccines, tests and treatments to all who need it in the world.

"Today, we go one step further. The European Commission is ready to join the COVAX Facility.

"This COVAX Facility is being designed to organize the procurement of vaccines against coronavirus at global level. We will join COVAX together with our EU member states, as Team Europe.

Advertisement

"The Commission will also make a contribution of 400 million euro in guarantees to the COVAX Facility and its goals. This contribution will help buy and deliver doses of future vaccines for low- and middle income countries.

"In parallel, we continue negotiating with pharmaceutical companies to purchase doses of vaccines on behalf of EU Member States.

Because one thing is clear: we will not be safe until everyone, whether here in Europe, or out there in the world, is safe. We need global solidarity. The European Commission’s contribution to COVAX brings us one step closer to this goal."

Watch President von der Leyen's video message here.

The European Commission has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere, for everyone who needs them. As part of a Team Europe effort, the Commission is today also announcing a contribution of €400 million in guarantees to support COVAX and its objectives in the context of the Coronavirus Global Response.

The COVAX Facility, co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, aims to accelerate the development and manufacture of COVID-19 vaccines and to guarantee fair and equitable access for every country in the world.

A full press release is available here.

Share this article:

Share this:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending